Abstract
OBJECTIVE: There is increasing public discussion of the value of disclosing how physicians are paid. However, little is known about patients’ awareness of and interest in physician payment information or its potential impact on patients’ evaluation of their care.
DESIGN: Cross-sectional survey.
SETTING: Managed care and indemnity plans of a large, national health insurer.
PARTICIPANTS: Telephone interviews were conducted with 2,086 adult patients in Atlanta, Ga.; Baltimore, Md/Washington DC; and Orlando, Fla (response rate, 54%).
MEASUREMENTS AND MAIN RESULTS: Patients were interviewed to assess perceptions of their physicians’ payment method, preference for disclosure, and perceived effect of different financial incentives on quality of care. Nonmanaged fee-for-service patients (44%) were more likely to correctly identify how their physicians were paid than those with salaried (32%) or capitated (16%) physicians. Just over half (54%) wanted to be informed about their physicians’ payment method. Patients of capitated and salaried physicians were as likely to want disclosure as patients of fee-for-service physicians. College graduates were more likely to prefer disclosure than other patients. Many patients (76%) thought a bonus paid for ordering fewer than the average number of tests would adversely affect the quality of their care. About half of the patients (53%) thought a particular type of withhold would adversely affect the quality of their care. White patients, college graduates, and those who had higher incomes were more likely to think that these types of bonuses and withholds would have a negative impact on their care. Among patients who believed that these types of bonuses adversely affected care, those with non-managed fee-for-service insurance and college graduates were more willing to pay a higher deductible or co-payment in order to get tests that they thought were necessary.
CONCLUSIONS: Most patients were unaware of how their physicians are paid, and only about half wanted to know. Most believed that bonuses or withholds designed to reduce the use of services would adversely affect the quality of their care. Lack of knowledge combined with strong attitudes about various financial incentives suggest that improved patient education could clarify patient understanding of the nature and rationale for different types of incentives. More public discussion of this important topic is warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gray BH. Trust and trustworthy care in the managed care era. Health Aff. 1997;16:34–49.
Cassel CK. The patient-physician covenant: an affirmation of asklepios. Ann Intern Med. 1996;124:604–6.
Morreim EH. Economic disclosure and economic advocacy: new duties in the medical standard of care. J Legal Med. 1991;12:275–329.
Levinson DF. Toward full disclosure of referral restrictions and financial incentives by prepaid health plans. N Engl J Med. 1987;317:1729–31.
Council on Ethical and Judicial Affairs, American Medical Association. Referral of patients: disclosure of limitations. In: Code of Medical Ethics: Current Opinions with Annotations. Chicago, IL: American Medical Association; 1996;1:128–9.
Morreim EH. Balancing act: The new medical ethics of medicine’s new economics. Washington, DC: Georgetown University Press, 1995.
Hall MA, Berenson RA. Ethical practice in managed care: a dose of realism. Ann Intern Med. 1998;128:395–402.
Miller TE, Sage WM. Disclosing physician financial incentives. JAMA. 1999;281:1424–30.
Pear R. Sweeping new rules are set out to protect people on Medicare. New York Times. June 23, 1998.
Pear R. Panel of experts urges broadening of patient rights. New York Times. October 23, 1997.
Preston J. Trenton seeks HMO disclosure of doctor’s financial incentives. New York Times. November 18. 1995.
Miller TE. Managed care regulation: in the laboratory of the states. JAMA. 1997;278:1102–9.
Khanna V, Silverman H, Schwartz J. Disclosure of operating practices by managed-care organizations to consumers of health-care: obligations of informed consent. J Clin Ethics. 1998;9:291–6.
Health Care Financing Administration. 42 CFR 417.479, December 31, 1996.
Morreim EH. To tell the truth: disclosing the incentives and limits of managed care. Am J Manag Care. 1997;3:35–43.
Gold MR, Hurley R, Lake T, Ensor T, Berenson R. A national survey of arrangements managed care plans make with physicians. N Engl J Med. 1995;333:1678–83.
Rodwin M. Medicine, money and morals. Oxford: Oxford University Press, 1993.
Kassirer JP. Managing care: should we adopt a new ethic? N Engl J Med. 1998;339:397–8.
Mechanic D, Schlesinger M. The impact of managed care on patients’ trust in medical care and their physicians. JAMA. 1996;275:1693–7.
Tumlinson A, Bottigheimer H, Mahoney P, Stone EM, Hendricks A. Choosing a health plan: what information will consumers use? Health Aff. 1997;16:229–38.
Chakraborty G, Ettenson R, Gaeth G. How consumers choose health insurance. J Health Care Marketing. 1994;14:21–33.
Klinkman MS. The process of choice of health care plan and provider: development of an integrated analytic framework. Med Care. 1991;29:295–330.
Cleary PD, Edgman-Levitan S. Health care quality: incorporating consumer perspectives. JAMA. 1997;278:1608–12.
Council on Medical Service, American Medical Association. Principles of Managed Care, Fourth Edition. Chicago, IL: American Medical Association; 1999;1–20.
Kao AC, Green DC, Davis NA, Koplan JP, Cleary PD. Patients’ trust in their physicians: Effects of choice, continuity, and payment method. J Gen Int Med. 1998;280:1708–14.
Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD. The relationship between method of physician payment and patient trust. JAMA. 1998;280:1708–14.
Physician Payment Review Commission. PPRC report on changes in physician practices. Sept. 1, 1995.
Landon BE, Wilson IB, Cleary PD. A conceptual model of the effects of health care organizations on the quality of medical care. JAMA. 1998;279:1377–82.
Mechanic D. Changing medical organization and the erosion of trust. Milbank Q. 1996;74:171–89.
Sulmasy DP. Physician, cost control and ethics. Ann Intern Med. 1992;116:920–6.
Blendon RJ, Brodie M, Benson JM, et al. Understanding the managed care backlash. Health Aff. 1998;17:80–94.
Chassin MR, Galvin RW, National Roundtable on Health Care Quality. The urgent need to improve health care quality. JAMA. 1998;280:1000–5.
LeBlang TR. Informed consent and disclosure in the physicianpatient relationship: expanding obligations for physicians in the United States. Med Law. 1995;14:429–44.
Appelbaum PS. Must we forgo informed consent to control health care costs. Milbank Q. 1993;71:669–76.
Pearson SD, Sabin JE, Emanuel EJ. Ethical guidelines for physician compensation based on capitation. N Engl J Med. 1998;339:689–93.
McLaughlin CG. Health care consumers: choices and constraints. Med Care Res Rev. 1999;56 Supp 1:24–59, 60–6.
Gawande AA, Blendon R, Brodie M, Benson JM, Levitt L, Hugick L. Does satisfaction with health plans stem from having no choices? Health Aff. 1998;17:184–94.
Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999.
Kerr EA, Hays RD, Mittman BS, Siu AL, Leake B, Brook RH. Primary care physicians’ satisfaction with quality of care in California capitated medical groups. JAMA. 1997;278:308–12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kao, A.C., Zaslavsky, A.M., Green, D.C. et al. Physician incentives and disclosure of payment methods to patients. J GEN INTERN MED 16, 181–188 (2001). https://doi.org/10.1111/j.1525-1497.2001.04139.x
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2001.04139.x